Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2015 Dec 28;55(3):196–207. doi: 10.1016/j.jaac.2015.12.011

Table 2.

Entry Characteristics

Variable AIM (n=31) Community Care (n=25)
Age, mean (SD) 9.3(1.6) 9.4(1.5)
Male (%) 20(65%) 19(76%)
Racial/ethnic minority (%) 12(39%) 9(36%)
IQ, mean (SD) 100.6(15.4) 100.7(10.6)
Entry Stimulant dose mg/kg/daya (SD) .90(.40) .90(.43)
Using outside counseling services (%) 18(58%) 15(60%)
Conduct disorder (%) 4(13%) 1(4%)
Oppositional defiant disorder (%) 29(94%) 24(96%)
Anxiety Disorders/Subthreshold Anxietyb (%) 9(29%) 11(44%)
Elevated parental ADHD symptoms (ASRS) (%) 17(55%) 7(28%)
Elevated parental depressive symptoms (BDI)(%) 9(29%) 7(28%)
Socioeconomic Index, c mean (SD) 42.3(15.2) 42.03(12.8)

Note: ADHD = attention-deficit/hyperactivity disorder; AIM = Novel therapy for ADHD plus Impairments in Mood; ASRS = Adult ADHD Self-Report Scale; BDI = Beck Depression Inventory

a

In methylphenidate equivalents on a mg/kg/day basis.

b

Anxiety symptoms assessed with the Schedule for Affective Disorders and Schizophrenia for School-Age Children: Present and Lifetime version (K-SADS-PL).

c

Based on Nakao and Treas (1994).